Proceedings: The effects of aspirin, carbenoxolone, and gefarnate on the gastric mucosal potential difference in man.
D001241:Aspirin / Q000494:pharmacology*; D004553:Electric Conductivity; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology*; D005745:Gastric Acidity Determination; D005753:Gastric Mucosa / Q000187:drug effects* / Q000503:physiopathology; D005756:Gastritis / Q000503:physiopathology; D006035:Glycyrrhiza; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010946:Plants, Medicinal; D012459:Salicylates / Q000097:blood; D012717:Sesquiterpenes / Q000494:pharmacology*; D013276:Stomach Ulcer / Q000503:physiopathology; D013386:Succinates / Q000494:pharmacology; D014315:Triterpenes / Q000494:pharmacology*
D005231:Fatty Acids, Unsaturated; D012459:Salicylates; D012717:Sesquiterpenes; D013386:Succinates; D014315:Triterpenes; D001241:Aspirin